相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Extended Structure of the APOBEC3G Catalytic Domain Suggests a Unique Holoenzyme Model
Elena Harjes et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
Rebecca A. Russell et al.
JOURNAL OF VIROLOGY (2009)
Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition
Yannick Bulliard et al.
JOURNAL OF VIROLOGY (2009)
APOBEC proteins and intrinsic resistance to HIV-1 infection
Michael H. Malim
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
Hendrik Huthoff et al.
PLOS PATHOGENS (2009)
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
MAPPIT (MAmmalian Protein-Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells
Els Pattyn et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization
Mark D. Stenglein et al.
JOURNAL OF VIROLOGY (2008)
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications
Lauren G. Holden et al.
NATURE (2008)
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G
Kuan-Ming Chen et al.
NATURE (2008)
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
Kotaro Shirakawa et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Functional domain organization of human APOBEOG
Barry D. Gooch et al.
VIROLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
Nuclear exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding
Ryan P. Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Model Structure of Human APOBEC3G
Kun-Lin Zhang et al.
PLOS ONE (2007)
Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation
Hendrik Huthoff et al.
JOURNAL OF VIROLOGY (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The APOBEC-2 crystal structure and functional implications for the deaminase AID
Courtney Prochnow et al.
NATURE (2007)
Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits
Joseph E. Wedekind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules
Susan L. Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G
Barbel Schrofelbauer et al.
JOURNAL OF VIROLOGY (2006)
A complex interaction pattern of CIS and SOCS2 with the leptin receptor
Delphine Lavens et al.
JOURNAL OF CELL SCIENCE (2006)
Biochemical activities of highly purified, catalytically active human APOBEC3G: Correlation with antiviral effect
Yasumasa Iwatani et al.
JOURNAL OF VIROLOGY (2006)
被撤回的出版物: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
YL Chiu et al.
NATURE (2005)
Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes
MA Khan et al.
JOURNAL OF VIROLOGY (2005)
Complementary function of the two catalytic domains of APOBEC3G
F Navarro et al.
VIROLOGY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
MAFFT version 5: improvement in accuracy of multiple sequence alignment
K Katoh et al.
NUCLEIC ACIDS RESEARCH (2005)
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
HZ Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to vif action
B Mangeat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
HP Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
R Schröfelbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
A Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines
YK Yu et al.
GENES & DEVELOPMENT (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
W Zennou et al.
JOURNAL OF VIROLOGY (2004)
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
YH Zheng et al.
JOURNAL OF VIROLOGY (2004)
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor
A Schäfer et al.
VIROLOGY (2004)
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
SG Conticello et al.
CURRENT BIOLOGY (2003)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells
I Lemmens et al.
NUCLEIC ACIDS RESEARCH (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
MAPPIT: a cytokine receptor-based two-hybrid method in mammalian cells
J Tavernier et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Design and application of a cytokine-receptor-based interaction trap
S Eyckerman et al.
NATURE CELL BIOLOGY (2001)
Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
S Eyckerman et al.
FEBS LETTERS (2000)
分享论文
